WASHINGTON (Reuters) - The Supreme Court on Tuesday declined to review a ruling that Abbott Laboratories' Humira arthritis drug did not infringe a patent owned by a Johnson & Johnson subsidiary and that threw out a $1.67 billion damage award a...
Source: http://health.yahoo.net/news/s/nm/supreme-court-won-t-review-j-j-abbott-patent-case
Jesus Receipt design John Edwards Jorja Fox
No comments:
Post a Comment
Note: only a member of this blog may post a comment.